| 1 |
Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009[J]. J Heart Lung Transplant, 2009, 28(10): 1031-1049.
|
| 2 |
Chan CC, Abi-Saleh WJ, Arroliga AC, et al., Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients[J]. J Heart Lung Transplant, 1996, 15(2): 196-205.
|
| 3 |
Kanj SS, Tapson V, Davis RD, et al. Infections in patients with cystic fibrosis following lung transplantation[J]. Chest, 1997, 112(4): 924-930.
|
| 4 |
Dengler TJ, Strnad N, Bühring I, et al., Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation[J]. Transplantation, 1998, 66(10): 1340-1347.
|
| 5 |
Reams BD, Musselwhite LW, Zaas DW, et al. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation[J]. Am J Transplant, 2007, 7(12): 2802-2808.
|
| 6 |
Villanueva J, Bhorade SM, Robinson JA, et al. Extracorporeal photopheresis for the treatment of lung allograft rejection[J]. Ann Transplant, 2000, 5(3): 44-47.
|
| 7 |
Meloni F, Cascina A, Miserere S, et al. Peripheral CD4(＋)CD25(＋) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients[J]. Transplant Proc, 2007，39(1): 213-217.
|
| 8 |
Cahill BC, O’Rourke MK, Strasburg KA, et al., Methotrexate for lung transplant recipients with steroid-resistant acute rejection[J]. J Heart Lung Transplant, 1996，15(11): 1130-1137.
|
| 9 |
Keenan RJ, Iacono A, Dauber JH, et al., Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients[J]. J Thorac Cardiovasc Surg, 1997, 113(2):335-340; discussion 340-341.
|
| 10 |
Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria[J]. J Heart Lung Transplant, 2002, 21(3):297-310.
|
| 11 |
Neurohr C, Huppmann P, Samweber B, et al., Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients[J]. J Heart Lung Transplant, 2009，28(5):468-474.
|
| 12 |
Gabbay E, Walters EH, Orsida B, et al. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase[J]. Am J Respir Crit Care Med, 2000，162(6): 2182-2187.
|
| 13 |
Stanbrook MB, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans[J]. Am J Respir Crit Care Med, 1999，160(6): 2034-2039.
|
| 14 |
Golocheikine AS, Saini D, Ramachandran S, et al. Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation[J]. Transpl Immunol, 2008 ，18(3): 260-263.
|
| 15 |
Kawut SM, Lederer DJ, Keshavjee S, et al. Outcomes after lung retransplantation in the modern era[J]. Am J Respir Crit Care Med, 2008. 177(1): 114-120.
|
| 16 |
Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis[J]. Proc Am Thorac Soc, 2009, 6(1): 79-93.
|
| 17 |
Ruttmann E, Ulmer H, Marchese M, et al. Evaluation of factors damaging the bronchial wall in lung transplantation[J]. J Heart Lung Transplant, 2005，24(3):275-281.
|
| 18 |
Herrera JM, McNeil KD, Higgins RS, et al., Airway complications after lung transplantation: treatment and long-term outcome[J]. Ann Thorac Surg, 2001, 71(3): 989-993; discussion 993-994.
|
| 19 |
Alvarez A, Algar J, Santos F, et al., Airway complications after lung transplantation: a review of 151 anastomoses[J]. Eur J Cardiothorac Surg, 2001，19(4): 381-387.
|
| 20 |
Holmes RD, Sokol RJ. Epstein-Barr virus and post-transplant lymphoproliferative disease[J]. Pediatr Transplant, 2002, 6(6): 456-464.
|